Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore
Natco Pharma reported over two-fold increase in consolidated profit after tax at ₹ 181.6 crore for the second quarter ended September 30, 2018. The company had posted a consolidated profit after tax of ₹ 84.4 crore in the same quarter last fiscal, Natco Pharma said in a regulatory filing.
Total revenue during the period under review stood at ₹ 583.5 crore. It was at ₹ 432.2 crore in the year-ago quarter. The company said its board of directors at its meeting on Monday had approved the buyback of fully paid-up equity shares of face value of ₹ 2 each at a price not exceeding ₹ 1,000 per share for an aggregate amount of ₹ 2,50 crore from the open market through stock exchange mechanism. The maximum buyback size represents 8.10 per cent and 8.22 per cent of the aggregate of the total paid up equity capital and free reserves, respectively, of the company, it added.
You May Interested In
2026-08-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Fuhrmann Hanlin Reports Strong Performance in the First Three Quarters of 2023
-
Chinese pharmaceutical companies enter overseas to record with up to $5 billion in licensing fees!
-
Roche's TIGIT Monoclonal Antibody Collapses Again, And A Large Number of Domestic Biopharmaceutical Companies are Deployed
-
Yantai Development Zone builds an integrated industrial chain of pharmaceutical R&D and manufacturing to promote the industrialization of new biological drugs
-
Why Chinese biopharmaceutical companies building factories to expand production
-
Bridgestone Reports Q3 Growth Amid Challenging North American Market
-
China’s Chemical “Spring Surge”: 68.8% of Products Rising—Real Recovery or Just a Pre-Festival Mirage?
-
Blue from the Rainforest: EFSA Greenlights Natural “Jagua Blue” as Safe Food Colorant
-
From Eggshell to Elixir: EFSA Declares Egg Membrane Collagen Peptides Safe for Adult Supplements
-
Toxic Ammonia Leak Prompts Emergency Response in Mississippi
Recommend Reading
-
![Lanxess Reports Challenging Third Quarter Amid Weak Global Demand and Geopolitical Uncertainty]()
Lanxess Reports Challenging Third Quarter Amid Weak Global Demand and Geopolitical Uncertainty
-
![EU Blocks Entry of Chinese Food Supplement Due to Unauthorized Ingredient]()
EU Blocks Entry of Chinese Food Supplement Due to Unauthorized Ingredient
-
![Trinseo Faces Pressure in Resin Markets but Sees Growth in Recycled Products]()
Trinseo Faces Pressure in Resin Markets but Sees Growth in Recycled Products
-
![Sika Undertakes Structural Adjustments Amid Weak Markets]()
Sika Undertakes Structural Adjustments Amid Weak Markets
-
![Probiotic Promise, Safety Snag: EFSA Gives Mixed Verdict on Multi-Strain Dog Feed Additive]()
Probiotic Promise, Safety Snag: EFSA Gives Mixed Verdict on Multi-Strain Dog Feed Additive
-
![This Week, the Price of Polyester Bottle Chips First Increased and Then Decreased, Falling Within the Week]()
This Week, the Price of Polyester Bottle Chips First Increased and Then Decreased, Falling Within the Week
-
![Phosphoric Acid: Uses in Cola, Rust Removal, and Fertilizers Explained]()
Phosphoric Acid: Uses in Cola, Rust Removal, and Fertilizers Explained
-
![This Week, the Transaction Focus of China's Propylene Oxide Market Rises (11.10-11.14)]()
This Week, the Transaction Focus of China's Propylene Oxide Market Rises (11.10-11.14)
-
![This Week's Epichlorohydrin Market Transaction Focus Shifted Upward and Stabilized (11.10-11.14)]()
This Week's Epichlorohydrin Market Transaction Focus Shifted Upward and Stabilized (11.10-11.14)
-
![Multiple Positive Factors Support a Rise in the Butadiene Market]()
Multiple Positive Factors Support a Rise in the Butadiene Market
